Bruker Avance DRX

The Bruker Avance DRX is a high-performance Nuclear Magnetic Resonance (NMR) spectrometer designed for detailed molecular analysis across various scientific disciplines. Introduced in the late 1990s, this instrument has been instrumental in advancing research in biotechnology, molecular biology, and pharmaceutical development.

Key features include:

• Versatile Probe Options: Accommodates multiple probe types, such as the 5 mm Bruker 1H/X Broadband observe probe, enabling detection of a wide range of nuclei including 15N, 31P, and 19F.

• Temperature Control: Supports experiments across a broad temperature range, from -100°C to +150°C, facilitating studies of temperature-dependent molecular dynamics.

• High Sensitivity and Resolution: Delivers precise spectral data essential for elucidating complex molecular structures.

• Advanced Software Integration: Operates with Bruker's TopSpin software, providing a user-friendly interface for data acquisition and analysis.

This spectrometer is widely utilised in:

• Biotechnology: Essential for protein structure determination, metabolomics, and drug discovery.

• Molecular Biology: Facilitates studies of nucleic acids, lipids, and other biomolecules.

• Pharmaceutical Research: Supports quality control, compound identification, and formulation analysis.

Commonly found in university laboratories, biomedical research centres, and pharmaceutical companies, the Bruker Avance DRX has been a cornerstone in scientific research since its release. While newer models like the Avance III have succeeded it, the DRX series remains in use due to its reliability and robust performance.